Accès ouvert

Myricetin exerts potent anticancer effects on human skin tumor cells

Article scientifique 2018 Anglais

Résumé

Purpose: To evaluate the anticancer activity of myricetin against skin cancer A431 cell lines.Methods: Cell viability was determined by MTT and colony formation assays. Apoptosis was determined by DAPI and annexin V/PI staining. Cell cycle, ROS and MMP analysis were performed by flow cytometry. Cell migration and invasion were assessed by Boyden Chamber assay, while protein expression was determined using western blotting.Results: Myricetin showed considerable anticancer activity against skin A431 cancer cell lines. However, lower cytotoxic effects were observed in normal FR2 cells. The anticancer activity of myricetin was due to ROS-prompted alterations in mitochondrial membrane potential and initiation of apoptotic cell death. The expressions of Bcl-2 and Bax were altered in response to myricetin treatment. Myricetin also induced cell cycle arrest and suppressed the migration and invasion of A431 cells.Conclusion: These results suggest that myricetin may be an important lead molecule for the development of a suitable treatment of skin cancer.Keywords: Skin carcinoma, ROS, Apoptosis, Myricetin, Cell migration

Citer ce document

Sun, W., Tao, Y., Yu, D., Zhao, T., Wu, L., Yu, W., Han, W. (2018). Myricetin exerts potent anticancer effects on human skin tumor cells. https://doi.org/10.4314/tjpr.v17i6.13

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Statistiques

Consultations : 1

Téléchargements : 0